October 06, 2025
Barriers to increasing guideline-recommended CRC screening rates are slow to fall, but ongong focused counseling and advocacy in primary care will support the progress.
October 05, 2025
Discover essential insights and innovative strategies at FMX 2025, featuring key topics like AI in healthcare and advancements in family medicine.
October 04, 2025
Get a first look at can’t-miss sessions from day 2 of FMX 2025—from vaccines and metabolic health to dementia, women’s care, and AI in family medicine.
October 03, 2025
Semaglutide and tirzepatide "should be first-line treatment" for people with obesity and its myriad of complications, says EU obesity professional association.
October 03, 2025
From vaccines to reproductive health to AI, here are 16 sessions you won't want to miss at FMX 2025.
October 03, 2025
The ReCODE program targets metabolic, infectious, immune, vascular, and toxic exposures, elements that underlie both mood and cognition, study authors said.
October 03, 2025
FDA did not announce the September 30 approval, which took place despite strong partisan opposition and during an uncompleted review of the drug's safety.
October 02, 2025
Moore describes the ACIP's shared decision making approach to COVID-19 vaccination as a "passive recommendation" that will surely exclude at-risk US populations.
October 02, 2025
Today's episode highlights arrhythmias as CVD risk markers, influenza vaccine safety, salt substitute use, preconception CT scan risks, and global diabetes care gaps.
October 02, 2025
The premonitory constellation of neurologic, autonomic, and behavioral symptoms is increasingly understood as the earliest manifestation of migraine pathophysiology.